Iovance Biotherapeutics, Inc. (IOVA)

Trade IOVA now with
9/23/2021 7:47:29 AM Iovance Biotherapeutics Begins Clinical Supply Of TIL Cell Therapy Manufactured At Iovance Cell Therapy Center
6/29/2021 6:34:47 AM Iovance Biotherapeutics Announces Clinical Data For LN-145 In Non-Small Cell Lung Cancer
12/14/2020 7:06:14 AM Iovance Biotherapeutics Appoints Jean-Marc Bellemin As CFO
1/15/2020 8:20:46 AM Iovance Completes Patient Dosing In Registration-Enabling Cohort 4 Of C-144-01 Melanoma Study With Lifileucel
1/12/2020 8:07:27 PM Iovance And Cellectis Enter Into Research Collaboration And Exclusive Worldwide License Deal
1/12/2020 8:05:00 PM Iovance Biotherapeutics Obtains License To Develop And Commercialize Novel IL-2 Analog
4/10/2018 8:45:12 AM B. Riley FBR Upgrades Iovance Biotherapeutics, Inc. (IOVA) To Buy From Neutral With $22 Price Target